Cargando…

P900: INVOLVED/UNINVOLVED SERUM FREE LIGHT CHAIN RATIO IS A STRONGER PREDICTOR OF DIAGNOSTIC/RISK FACTORS IN LIGHT CHAIN COMPARED TO HEAVY CHAIN MONOCLONAL GAMMOPATHIES

Detalles Bibliográficos
Autores principales:	Thorir Oskarsson, Jon, Þorsteinsdóttir, Sigrún, Rögnvaldsson, Sæmundur, Ásta Sigurðardóttir, Guðrún, Rósa Þórðardóttir, Ásdís, Kjartan Gíslason, Gauti, Ólafsson, Andri, Kristinn Sigurðsson, Jón, Eyþórsson, Elías, Jónsson, Ásbjörn, Viðarsson, Brynjar, Torfi Önundarson, Páll, Agnar Agnarsson, Bjarni, Palmason, Robert, Sigurðardóttir, Margrét, Þorsteinsdóttir, Ingunn, Ólafsson, Ísleifur, Harding, Stephen, Durie, Brian, Jon Love, Thorvardur, Yngvi Kristinsson, Sigurdur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431161/ http://dx.doi.org/10.1097/01.HS9.0000970504.15034.c8

Ejemplares similares

Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study
por: Long, Thorir Einarsson, et al.
Publicado: (2022)

Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality index
por: Óskarsson, Jón Þórir, et al.
Publicado: (2023)

P894: INFECTION RISK BEFORE DIAGNOSIS OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: RESULTS FROM THE SCREENED POPULATION-BASED ISTOPMM STUDY
por: Ros Levy, Marina, et al.
Publicado: (2023)

P950: PRIOR CANCER AND RISK OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS): A POPULATION-BASED STUDY IN ICELAND AND SWEDEN
por: Rögnvaldsson, Sæmundur, et al.
Publicado: (2023)

Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study
por: Sigurbergsdóttir, Aðalbjörg Ýr, et al.
Publicado: (2023)

Sars-Cov-2 Vaccinations Do Not Lead to Progression of Monoclonal Gammopathy of Undetermined Significance: Results from the Population-Based Istopmm Screening Study
por: Palmason, Robert, et al.
Publicado: (2022)

Monoclonal Gammopathy of Undetermined Significance and COVID-19: Results from the Population-Based Iceland Screens Treats or Prevents Multiple Myeloma Study (iStopMM)
por: Rögnvaldsson, Sæmundur, et al.
Publicado: (2021)

Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study
por: Rognvaldsson, Saemundur, et al.
Publicado: (2021)

Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies
por: Rögnvaldsson, Sæmundur, et al.
Publicado: (2021)

Correction: Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies
por: Rögnvaldsson, Sæmundur, et al.
Publicado: (2023)

Involved/uninvolved heavy/light chain index can predict progression in transplanted multiple myeloma patients
por: Espiño, M, et al.
Publicado: (2017)

Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2018)

Prevalence of modifiable risk factors in primary elective arthroplasty and their association with infections
por: SIGURDARDOTTIR, Maria, et al.
Publicado: (2023)

Light Chain Restriction in Proximal Tubules—Implications for Light Chain Proximal Tubulopathy
por: Büttner-Herold, Maike, et al.
Publicado: (2022)

Association of Genetically Predicted Lipid Levels With the Extent of Coronary Atherosclerosis in Icelandic Adults
por: Björnsson, Eythór, et al.
Publicado: (2019)

Light chain myeloma and detection of free light chains in serum and urine of dogs and cats
por: Harris, Robert Adam, et al.
Publicado: (2021)

Clathrin Light Chains: Not to Be Taken so Lightly
por: Das, Jyoti, et al.
Publicado: (2021)

Antibodies, hold the light chain
por: Bashyam, Hema, et al.
Publicado: (2007)

LIGHT CHAIN DEPOSITION DISEASE
por: Vos, Josephine M.I.
Publicado: (2022)

Rare SCARB1 mutations associate with high-density lipoprotein cholesterol but not with coronary artery disease
por: Helgadottir, Anna, et al.
Publicado: (2018)

INDEPENDENT SYNTHESIS OF LIGHT AND HEAVY CHAINS : Quantitation of Light-Chain Production by Mouse Myeloma Variants
por: Laskov, Reuven, et al.
Publicado: (1974)

Differences in Immunoglobulin Light Chain Species Found in Urinary Exosomes in Light Chain Amyloidosis (AL)
por: Ramirez-Alvarado, Marina, et al.
Publicado: (2012)

Botulinum Neurotoxin Heavy Chain Belt as an Intramolecular Chaperone for the Light Chain
por: Brunger, Axel T, et al.
Publicado: (2007)

Advanced isolated light chain amyloid cardiomyopathy with negative immunofixation and normal free light chain ratio
por: Zach, David, et al.
Publicado: (2021)

Polyclonal light chains in cerebrovascular disease
por: Fiori, Patrizia, et al.
Publicado: (2010)

Novel Therapies in Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2017)

DUAL expectations in light chain amyloidosis
por: Schönland, Stefan, et al.
Publicado: (2020)

Observations on hematogones with light chain restriction.
por: D'Ardia, Angela, et al.
Publicado: (2022)

Neurofilament light chain: defining the analyte
por: Leckey, Claire A., et al.
Publicado: (2022)

Novel renal replacement strategies for the elimination of serum free light chains in patients with kappa light chain nephropathy
por: Kleeberg, L, et al.
Publicado: (2009)

Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies
por: Tietsche de Moraes Hungria, Vania, et al.
Publicado: (2016)

Coexistent Amyloid Fibrils in a Patient with Combined Light Chain Deposition Disease and Light Chain Cast Nephropathy
por: Anandh, Urmila, et al.
Publicado: (2019)

Evidence for Transition From Light Chain Deposition Disease by Immunofluorescence-Only to Classic Light Chain Deposition Disease
por: Nasr, Samih H., et al.
Publicado: (2021)

Heavy chain–only antibodies are spontaneously produced in light chain–deficient mice
por: Zou, Xiangang, et al.
Publicado: (2007)

Defective Kinesin Heavy Chain Behavior in Mouse Kinesin Light Chain Mutants
por: Rahman, Amena, et al.
Publicado: (1999)

Chromosomal location of structural genes encoding murine immunoglobulin lambda light chains. Genetics of murine lambda light chains
Publicado: (1981)

Mutations in Specific Structural Regions of Immunoglobulin Light Chains Are Associated with Free Light Chain Levels in Patients with AL Amyloidosis
por: Poshusta, Tanya L., et al.
Publicado: (2009)

A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosis
por: Sharpley, Faye A., et al.
Publicado: (2019)

Clinicopathological characteristics of light chain proximal tubulopathy in Korean patients and the diagnostic usefulness of immunohistochemical staining for immunoglobulin light chain
por: Jung, Minsun, et al.
Publicado: (2020)

Structural analysis of urinary light chains and proteomic analysis of hyaline tubular casts in light chain associated kidney disorders
por: Reiter, Thomas, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lvdu4ji2hqsb3ssihp70l22mch